Sheep give Bioventix the advantage in immunodiagnostic market
This article was originally published in Clinica
Executive Summary
Rodents have long been used to provide monoclonal antibodies for the diagnostic testing market. However, UK firm Bioventix has pioneered the use of sheep cells to create more effective antibodies. Joseph Harvey met the firm’s CEO Peter Harrison to find out why sheep are the way forward for diagnostics